Indiana University Melvin and Bren Simon Cancer Center — Indianapolis, Indiana

Public research footprint of Indiana University Melvin and Bren Simon Cancer Center, compiled from the ClinicalTrials.gov public registry.

485

Registered studies

169

Active

Recruiting now

234

Completed

Stopped or withdrawn

Most-studied conditions

Endometrial Dedifferentiated Carcinoma · Recurrent Melanoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Endometrial Clear Cell Adenocarcinoma

Recently updated registry entries

NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT01142388 — Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With… (Active Not Recruiting)
NCT00114101 — Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Indiana University Melvin and Bren Simon Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.